The founder of Apple and its chief executive Steve Jobs, a survivor of pancreatic cancer, stated recently that a hormone imbalance is what caused his weight loss that was widely reported by the media. Jobs, 53, said he will receive a “relatively simple” treatment and will remain the head of the company. Investors seemed happy to have some clarity on his health. Apple’s shares rose $3.42, 3.8 per cent, to $94.17 in early trading.
Speculation about Jobs’ health permeated in 2008 as he appeared slim in his public events. The rumours compounded after Apple decied in December that Jobs would not be making his annual keynote speech on Tuesday in San Francisco at the Macworld conference.
Officially Apple stated Jobs would not give the presentation since this year will mark the company’s last appearance at the show, which is held by a separate company, the IDG technology media group. Phil Schiller, an Apple marketing executive, would give the company’s presentation instead.
Some analysts have began questioning the company’s viability without Jobs, who has emphasized the design principles that made standouts out of Apple’s Mac computers, iPods and iPhones.
In his letter Monday, Jobs said, “I will be the first one to step up and tell our board of directors if I can no longer continue to fulfil my duties as Apple’s CEO.”







Today’s